Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com

Stock Price vs Company Growth
1d
2.9%
1w
3.2%
1m
0.6%
3m
9.6%
6m
42.8%
1y
47.8%
5y
21.8%
10y
9.8%
all
1.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 12.1 2.9%
9.2
14.9
Company Overview

Sales
288 Cr
Growth: -12.5%
Profit after Tax
-328 Cr
Growth: -15.9%
Micro Cap
234 Cr
P/S: 0.8x
Industry P/S: 2.6x
Fundamentals

Sales (Cr) ₹ 288
Growth -12.5%
EBITDA N/A
P/S 0.8x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1511.8%
P/B N/A
Shareholding Pattern

Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed

Nectar is a global pharmaceutical company specializing in Cephalosporins.
Investors (30)
Followers (2)